Search research articles
Contact Us
Filters
Showing results (1-10 of 91) with videos related to
Page
of 10
Sort By:
Current Pharmaceutical Design
|
January 29, 2008
Editorial: Angiogenesis agents
Cezary Marcinkiewicz
Current Pharmaceutical Design
|
February 10, 2009
Angiogenesis agents
Cezary Marcinkiewicz
The International Journal of Biochemistry & Cell Biology
|
July 2, 2013
Applications of snake venom components to modulate integrin activities in cell-matrix interactions
Cezary Marcinkiewicz
Current Pharmaceutical Design
|
November 6, 2007
Pharmacological impact of snake venom compounds
Cezary Marcinkiewicz
Current Pharmaceutical Design
|
March 22, 2005
Functional characteristic of snake venom disintegrins: potential therapeutic implication
Cezary Marcinkiewicz
Toxicon : Official Journal of the International Society on Toxinology
|
August 2, 2011
Non-RGD-containing snake venom disintegrins, functional and structural relations
Erin M Walsh, Cezary Marcinkiewicz
Current Pharmaceutical Design
|
July 18, 2006
Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development
Philip Lazarovici, Cezary Marcinkiewicz, Peter I Lelkes
Journal of Proteome Research
|
January 6, 2007
Snake venomics of Bitis gabonica gabonica. Protein family composition, subunit organization of venom toxins, and characterization of dimeric disintegrins bitisgabonin-1 and bitisgabonin-2
Juan J Calvete, Cezary Marcinkiewicz, Libia Sanz
Methods in Molecular Biology (Clifton, N.J.)
|
October 3, 2019
Cell-Based Adhesion Assays for Isolation of Snake Venom's Integrin Antagonists
Philip Lazarovici, Cezary Marcinkiewicz, Peter I Lelkes
Polskie Archiwum Medycyny Wewnetrznej
|
June 2, 2006
[Snake venom disintegrins--source of knowledge and development of the new drugs]
Stanisława Bazan-Socha, Cezary Marcinkiewicz, Jacek Musiał
Page
of 10
Search research articles
Search
Showing results (1-10 of 91) with videos related to
Sort By:
Page
of 10
Current Pharmaceutical Design
|
January 29, 2008
Editorial: Angiogenesis agents
Cezary Marcinkiewicz
Current Pharmaceutical Design
|
February 10, 2009
Angiogenesis agents
Cezary Marcinkiewicz
The International Journal of Biochemistry & Cell Biology
|
July 2, 2013
Applications of snake venom components to modulate integrin activities in cell-matrix interactions
Cezary Marcinkiewicz
Current Pharmaceutical Design
|
November 6, 2007
Pharmacological impact of snake venom compounds
Cezary Marcinkiewicz
Current Pharmaceutical Design
|
March 22, 2005
Functional characteristic of snake venom disintegrins: potential therapeutic implication
Cezary Marcinkiewicz
Toxicon : Official Journal of the International Society on Toxinology
|
August 2, 2011
Non-RGD-containing snake venom disintegrins, functional and structural relations
Erin M Walsh, Cezary Marcinkiewicz
Current Pharmaceutical Design
|
July 18, 2006
Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development
Philip Lazarovici, Cezary Marcinkiewicz, Peter I Lelkes
Journal of Proteome Research
|
January 6, 2007
Snake venomics of Bitis gabonica gabonica. Protein family composition, subunit organization of venom toxins, and characterization of dimeric disintegrins bitisgabonin-1 and bitisgabonin-2
Juan J Calvete, Cezary Marcinkiewicz, Libia Sanz
Methods in Molecular Biology (Clifton, N.J.)
|
October 3, 2019
Cell-Based Adhesion Assays for Isolation of Snake Venom's Integrin Antagonists
Philip Lazarovici, Cezary Marcinkiewicz, Peter I Lelkes
Polskie Archiwum Medycyny Wewnetrznej
|
June 2, 2006
[Snake venom disintegrins--source of knowledge and development of the new drugs]
Stanisława Bazan-Socha, Cezary Marcinkiewicz, Jacek Musiał
Page
of 10